Volume 6, Issue 21 (1-2016)                   NCMBJ 2016, 6(21): 117-121 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bikhof Torbati M, Shaabanzadeh M, Azadian S. Evaluation of Anti tumor properties of indoloquinazoline on MCF-7 cell line. NCMBJ 2016; 6 (21) :117-121
URL: http://ncmbjpiau.ir/article-1-770-en.html
Department of Biology ,College of science , Yadegar - e- Imam Khomeini 1 Islamic Azad University, Tehran ,Iran., RAH)shahre- rey Branch) , maryam.bikhof@gmail.com
Abstract:   (9016 Views)

Aim and Background: Chemotherapy is a category of cancer treatment that uses chemical agents. The harmfulness of chemotherapy on normal cells by killing cells is the most common side-effects of chemotherapy. Characterization and selection of new powerful chemotherapy agents which have low side effects are important. Indoloquinazoline has a variety of biological activities such as antimicrobial activities and cytotoxic properties. In this study, cytotoxic effect of synthetic indoloquinazoline compound was studied on breast cancer cell line and compared with cisplatin.

Materials and Methods: Anti tumor activity of indoloquinazoline compound and cisplatin was studied on breast cancer cell line, MCF-7, by MTT assay.

Results: Indoloquinazoline compound showed antitumor activity with IC50 of 6.83 µg/ml by being Compared with 39.13 µg/ml of cisplatin, as a kind of standard drug on MCF-7 cell line.

Conclusion: The results showed indoloquinazoline is cytotoxic more than cisplatin on MCF-7 cell line.

Full-Text [PDF 347 kb]   (4399 Downloads)    
Type of Study: Research Article | Subject: Cellular and molecular
Received: 2016/01/21 | Accepted: 2016/01/21 | Published: 2016/01/21

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | New Cellular and Molecular Biotechnology Journal

Designed & Developed by : Yektaweb